Elias Mossialos

Elias Mossialos (Ηλίας Μόσιαλος) Professor of Health Policy @LSE

[Hans Kluge @hans_kluge]

The Government of Belgium has nominated me for the position of WHO Director-General.

I am deeply honoured by the trust and confidence Belgium 🇧🇪has placed in me, and grateful for the opportunity to stand for this important responsibility.

Effective today, I will be on special leave from my role as WHO Regional Director for Europe, in accordance with WHO's established procedures. During this period, I look forward to engaging with Member States, partners and civil society listening to their perspectives, and exchanging views on the future of our Organization and global health.

I know that @WHO_Europe's important work will continue under the capable leadership of Dr Corinne Capuano during my period of special leave, and I wish Corinne every success in this responsibility.

My commitment to WHO, its Member States and the values of our Organization will remain unwavering, as will my deep respect for the outstanding leadership of @DrTedros, who has guided WHO through some of the most challenging moments in global health.

Serving @WHO has been the greatest privilege of my professional life. I approach this next chapter with humility, optimism and a steadfast commitment to the values that unite us in improving #HealthForAll.

[The Lancet @TheLancet]

In July 2025, the UK Government published the long-awaited NHS 10-year plan for England.

In a Viewpoint, authors identify key obstacles to implementing the plan & propose actions to improve implementation: https://t.co/2coup7eN0a

[The Lancet @TheLancet]

In July 2025, the UK Government published the long-awaited NHS 10-year plan for England.

In a new Viewpoint, authors identify key obstacles to implementing the plan & propose actions to improve implementation: https://t.co/p92y4Bbxov

[Int. Centre for Antimicrobial Resistance Solutions @ICARS_global]

Today's #MondayRead from @LancetMicrobe introduces the Swiss cheese model of antimicrobial resistance (#AMR), showing how successive imperfect layers of defence, when aligned effectively, can reduce risk and prevent system failure.

🔍 The model visualises 15 codependent layers across:
🔹 One Health contexts (human, animal, plant and environmental health),
🔹 Targeted interventions (#WASH, #IPC, stewardship, diagnostics, awareness)
🔹 Resource allocation (investment, workforce, innovation).

📢 The message is clear: Without sustained investment, strategic communication, and coordinated action, AMR will continue to threaten public health, undermine modern medicine, and impose substantial economic costs.

🧀 “When holes align, multiple system failures occur at once.” Coordinated, multisectoral responses are not optional; they are essential.

📄 Read the full paper here: https://t.co/T7Xe2O0plb

#AMR #OneHealth #HealthSystems #Stewardship #Diagnostics #GlobalHealth #MondayRead #Surveillance

[LSE @LSEnews]

🎉 Huge congratulations to Professor Lilie Chouliaraki on receiving the International Communication Association's (@icahdq) Outstanding Book Award for her timely book Wronged: The Weaponization of Victimhood, at #ICA25 this past weekend.

[LSE Health Policy @LSEHealthPolicy]

📌Our LSE Health Annual Lecture with @MichaelMarmot, Director of @marmotihe is just two weeks away!

‘Social Justice and Health Equity'

📅 Monday 17 March, 6:30pm- 8:00pm
ℹ️ Find out more https://t.co/XTiEbVnh5Z
📍LSE Campus & Online, register: https://t.co/o4hI7d2ukq

[LSE Health Policy @LSEHealthPolicy]

📌Don’t forget to register for LSE Health's online lecture with Anthony McDonnell, Policy Fellow @CGDev.

‘Understanding the economic burden of antimicrobial resistance'

ℹ️➡️Find out more: https://t.co/RgiFnw2XK8

📍Register to attend online here: https://t.co/18Ogf3UU1a

[Hans Kluge @hans_kluge]

What is human metapneumovirus #HMPV – the pathogen currently in the news coming from China?

It’s a fairly common respiratory virus that usually causes relatively mild symptoms like cough, fever, nasal congestion and wheezing.

Severe cases, however, can lead to pneumonia, especially in infants, the elderly or those with underlying conditions.

It spreads through droplets, close contact or contaminated surfaces.

Currently, there's no specific antiviral therapy to treat HMPV and no vaccine to prevent it.

Simple infection control measures – applicable to a range of respiratory diseases, from the common cold and influenza to #COVID19 and HMPV - can prevent spread and reduce risk:

☑️Stay home when ill and wear masks in crowded or poorly ventilated spaces.

☑️Cover coughs and sneezes with a tissue or bent elbow.

☑️Wash hands and clean surfaces regularly.

Stay informed. Stay safe.

2/

[WHO/Europe @WHO_Europe]

Antibiotics are lifesavers, but they are losing their effectiveness.

WHO/Europe & @LSEHealthPolicy are developing the first AMR Accountability Index to drive #AMR action in #Europe and #CentralAsia.

Read it here: https://t.co/d1RN1IytiN

#ActOnAMR
@hans_kluge @MOSSIALOS

[Lilie Chouliaraki @chouliaraki_l]

Wow! Brilliant reflection on Wronged in @EJCS_Journal.@kat_hig 🙏
Wronged opens new ways of thinking about the centrality of pain in political life, while inviting us to meet the challenge of reclaiming victimhood to build a more just, less painful world.
https://t.co/yTlQSn3QrS

[Hans Kluge @hans_kluge]

Antimicrobial resistance #AMR is one of the top global health threats of our time, potentially reversing significant medical breakthroughs of the past century. 

Following the mandate from our Member States, we are developing and piloting the first AMR Accountability Index, together with @LSEHealthPolicy. The aim is to pilot the Index in Europe and Central Asia from 2026.   

Targets are a highly valuable tool in our response to AMR. They provide clear, measurable objectives that focus efforts and resources on key areas.  

Targets can motivate stakeholders, including governments, healthcare providers and organizations, to prioritize AMR as a critical public health issue. 

Read our commentary here https://t.co/TdeFySDJSB

[Lilie Chouliaraki @chouliaraki_l]

Delighted by this review of “Wronged” at @LSEReviewBooks
“Chouliaraki’s book offers a powerful and nuanced analysis of how victimhood is politicised in contemporary society” https://t.co/Xg992gv3XR

[npj Digital Medicine @npjDigitalMed]

Another awesome thread from one of our super community of authors!

See below @robinvankessel's synopsis of this paper describing the policies that contribute to the regulatory landscape for #ArtificialIntelligence in health within the EU.

https://t.co/kcfxiCBcUi

Full thread quoted below...

[The Atlantic @TheAtlantic]

In her book "Wronged," the scholar Lilie Chouliaraki argues that the practice of claiming harm has become the rhetorical province of the powerful. She asks readers to turn to a basic yet hard-to-solve question, @lilyjmeyer writes: Who is vulnerable? https://t.co/fhUlUcIHB5

[Elias Mossialos @MOSSIALOS]

Two-tier Kier” is reverse victimisation, a classic far-right strategy of communication

[Lilie Chouliaraki @chouliaraki_l]

“Two-tier Kier” is reverse victimisation, a classic far-right strategy of communication, @kat_hig and I argue in this @LSEBPP blog post on the recent U.K. riots 👇

[Columbia University Press @ColumbiaUP]

Watch Lilie Chouliaraki (@chouliaraki_l), author of WRONGED, present her book within the context of abortion rights in America @LSENews. WRONGED reveals why claims of victimization are so effective at reinforcing inequalities of class, gender, and race. https://t.co/M5zqG0nLL2

[Lilie Chouliaraki @chouliaraki_l]

Friends! My book WRONGED: THE WEAPONIZATION OF VICTIMHOOD is now available: https://t.co/skOj6zfy3X @ColumbiaUP

[HOPE at UoM @HOPE_UoM]

New paper by Michael Anderson & colleagues.

It suggests that previous evidence indicating that private hospitals provide a higher quality of care compared to NHS hospitals may potentially overlook unobserved confounding at the patient-level.

https://t.co/A70CQmjAl5

[LSE Health Policy @LSEHealthPolicy]

🆕Dr Leeza Osipenko @consiliumsci, @IvaParvanova01, Professor @MOSSIALOS & colleagues' new paper analyses the origin & clinical benefits of first-in-class drugs.

🔗Read more about their findings here ➡ https://t.co/qMSz2992Ia

[Tomislav Sokol @TomislavSokol]

As #PHSSR EU Expert Advisory Group co-chair, I hosted an event in @EuroParl_EN, where we launched report dedicated to key policy recommendations on prevention&early detection of #NCDs in 🇪🇺. I want to thank co-chair @MOSSIALOS and other experts for their invaluable contributions.